Spruce Biosciences Inc (SPRB)

$0.08 +0.00 (5.47%)
Market Cap 3.32M
Revenue (ttm) 4.91M
Net Income (ttm) -53.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,080.24%
Debt to Equity Ratio 0.06
Volume 4,396,400
Avg Vol 1,630,932
Day's Range N/A - N/A
Shares Out 42.23M
Stochastic %K 30%
Beta 2.39
Analysts Hold
Price Target $1.50

Company Profile

Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Syndrome Type B. It also develops Tildacerfont for treating a highly debilitating mental disorder characterized by depressed mood with cognitive-affective and somatic changes, includ...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 655 4168
Address:
611 Gateway Boulevard, Suite 740, South San Francisco, United States
SQUEAKSBANDIT
SQUEAKSBANDIT Jun. 16 at 6:58 PM
$SPRB i'm posting this here and here only $BCYC negative EV a whole bunch of programs (check their website) baker brothers bought in at much higher prices felix baker taking over as chairman today do your own research I added today
1 · Reply
Ridiculous78
Ridiculous78 Jun. 16 at 2:47 PM
$SPRB Seems like they want to get relisted on the Nasdaq. Institutions still holding roughly 20%, severely bagged. Adding a couple thousand at .07c in the event of a RS / relist / pump into cash raise (likely).
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 13 at 2:58 PM
$SPRB buying interest near zero nobody seems to believe in their fantasies
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 13 at 1:48 PM
$SPRB as expected - the fake pump is over
1 · Reply
joe77w
joe77w Jun. 12 at 8:37 PM
$SPRB after ER THERAPY approval, Company could be worth north of 300 mln usd so I dont care about offering, when orphan drug approved, and Priority review voucher granted, 80% chance approval
0 · Reply
joe77w
joe77w Jun. 12 at 6:55 PM
$SPRB the most undervalued stock, I would buy a ton at this silly price. Huge catalysts ahead, trading at a fraction of cash, rare disease drig potential approval next year with Priority Review Voucher worth 150 mln usd. Current market cap 3 mln usd woth 20 mln in net cash, absurd
1 · Reply
joe77w
joe77w Jun. 12 at 3:04 PM
$SPRB .25 again when relisted, one of the most undervalued stock on the earth imo
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Jun. 12 at 2:56 PM
$SPRB please, will anyone raise their hand and admit they just sold their shares on that sucker pop? please even one of you guys ? shares will in all likelihood be .06 again
1 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 12 at 2:10 PM
$SPRB obviously nothing left from the premarket hype (0,11$)
1 · Reply
motor2
motor2 Jun. 12 at 2:08 PM
$SPRB https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-announces-conditional-nasdaq-approval-resume
0 · Reply
Latest News on SPRB
No data available.
SQUEAKSBANDIT
SQUEAKSBANDIT Jun. 16 at 6:58 PM
$SPRB i'm posting this here and here only $BCYC negative EV a whole bunch of programs (check their website) baker brothers bought in at much higher prices felix baker taking over as chairman today do your own research I added today
1 · Reply
Ridiculous78
Ridiculous78 Jun. 16 at 2:47 PM
$SPRB Seems like they want to get relisted on the Nasdaq. Institutions still holding roughly 20%, severely bagged. Adding a couple thousand at .07c in the event of a RS / relist / pump into cash raise (likely).
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 13 at 2:58 PM
$SPRB buying interest near zero nobody seems to believe in their fantasies
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 13 at 1:48 PM
$SPRB as expected - the fake pump is over
1 · Reply
joe77w
joe77w Jun. 12 at 8:37 PM
$SPRB after ER THERAPY approval, Company could be worth north of 300 mln usd so I dont care about offering, when orphan drug approved, and Priority review voucher granted, 80% chance approval
0 · Reply
joe77w
joe77w Jun. 12 at 6:55 PM
$SPRB the most undervalued stock, I would buy a ton at this silly price. Huge catalysts ahead, trading at a fraction of cash, rare disease drig potential approval next year with Priority Review Voucher worth 150 mln usd. Current market cap 3 mln usd woth 20 mln in net cash, absurd
1 · Reply
joe77w
joe77w Jun. 12 at 3:04 PM
$SPRB .25 again when relisted, one of the most undervalued stock on the earth imo
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Jun. 12 at 2:56 PM
$SPRB please, will anyone raise their hand and admit they just sold their shares on that sucker pop? please even one of you guys ? shares will in all likelihood be .06 again
1 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 12 at 2:10 PM
$SPRB obviously nothing left from the premarket hype (0,11$)
1 · Reply
motor2
motor2 Jun. 12 at 2:08 PM
$SPRB https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-announces-conditional-nasdaq-approval-resume
0 · Reply
kebrik
kebrik Jun. 12 at 1:47 PM
Today's movers: $HCTI, $IPA, $NEHC, $CETX, and $SPRB
0 · Reply
mikedumbledar
mikedumbledar Jun. 12 at 1:28 PM
$SPRB this too 👇
0 · Reply
mikedumbledar
mikedumbledar Jun. 12 at 12:47 PM
$SPRB understand this
0 · Reply
MasterOfMyDomains
MasterOfMyDomains Jun. 12 at 12:16 PM
$SPRB Well, you failed. We are pleased by Nasdaq’s decision to lift its trading suspension and resume trading of our common stock on or before August 5, 2025 , subject to our compliance with the minimum bid price requirement,” said Samir Gharib , President and Chief Financial Officer of Spruce. “We are diligently working to regain compliance with the minimum bid price requirement by seeking stockholder approval to effect a reverse stock split of our common stock at our upcoming 2025 Annual Meeting of Stockholders. We strongly encourage all stockholders entitled to vote at the 2025 Annual Meeting of Stockholders to vote in favor of the reverse stock split proposal (Proposal No. 3).”
1 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 9 at 6:27 PM
$SPRB reverse-split 1:100 in preparation so stock price should be around $6.00 afterwards
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 9 at 7:10 AM
$SPRB on the whole the chance for a return to NASDAQ in the next 12 months is near ZERO
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 9 at 7:06 AM
$SPRB
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Jun. 9 at 1:34 AM
$SPRB does anyone think that this stays above a buck after the reverse? if anything its being done to facilitate the recapitalization i don't believe this name will ever trade on the nasdaq again one thing is certain, if you see a pump, SELL EVERY FRIGGIN SHARE AND NEVER LOOK BACK
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 6 at 7:06 PM
$SPRB the chances of relisting on NASDAQ are less than 10%
1 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 4 at 7:33 PM
$SPRB preparation of annual meeting under full steam
0 · Reply
mikedumbledar
mikedumbledar May. 29 at 7:24 PM
$SPRB just a reminder: FDA told them to apply for Breakthrough Therapy Designation. The company said they will do so. it takes FDA 60 days to approve the application That news could come as early as June/July 2025
0 · Reply
mikedumbledar
mikedumbledar May. 29 at 7:20 PM
$SPRB one of the most mispriced biotechs out there. they will come for this bigly soon
0 · Reply